Literature DB >> 16751165

The effects of amifostine and dexamethasone on brain tissue lipid peroxidation during oxygen treatment of carbon monoxide-poisoned rats.

Habip Atalay1, Hülya Aybek, Mehmet Koseoglu, Suleyman Demir, Hakan Erbay, Ali Zahit Bolaman, Aslihan Avci.   

Abstract

The mechanisms of injury of, and methods of treating patients with, carbon monoxide (CO) poisoning are poorly understood. Besides the hypoxic degenerative effects of CO, reoxygenation injury may play an important role. Amifostine (Ami), which is most often used in radiotherapy for its tissue protective characteristics, may offer benefits. In this study, investigators evaluated the effectiveness of various treatments in a CO-poisoned rat model. A total of 36 Wistar rats were randomly assigned to 1 of 6 groups (n=6 each), including control and poisoned groups exposed to CO at 2000 ppm (v/v) for 1 h, followed by various 1-h treatments: group C (control), group COair (ambient air), group CO-NBO (normobaric 100% oxygen), group CO-HBO (hyperbaric oxygen with 3 atmospheres absolute [3 ATA]), group CO-NBO-Ami (normobaric oxygen with intraperitoneal [i.p.] injection of amifostine 250 mg/kg body weight [bw]), and group CO-70O (70% O2 and 5% CO2 with dexamethasone 10 mg/kg bw, i.p.). Blood gas analysis, carboxyhemoglobin determination, brain tissue lipid peroxidation, and glutathione peroxidase (GSHPx), superoxide dismutase (SOD), lactate dehydrogenase (LDH), and creatine kinase (CK) activities were evaluated. Carboxyhemoglobin concentration in the air-treated group was 44+/-2%; it decreased to the control level with all oxygen treatments. Brain tissue GSH-Px and SOD measurements did not change. The activity of LDH in group CO-HBO and the activities of LDH and CK in group CO-70O were similar to those of group C. Lipid peroxides were high in ambient air and normobaric oxygen, but HBO, amifostine with oxygen, or 70% O2 reduced these to control levels (P<.05).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751165     DOI: 10.1007/bf02850138

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  4 in total

Review 1.  Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy.

Authors:  Jason J Rose; Ling Wang; Qinzi Xu; Charles F McTiernan; Sruti Shiva; Jesus Tejero; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

2.  Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.

Authors:  E A Prieto González; A G Fuchs; González S Sánchez
Journal:  Dose Response       Date:  2009-06-11       Impact factor: 2.658

3.  Combined application of dexamethasone and hyperbaric oxygen therapy yields better efficacy for patients with delayed encephalopathy after acute carbon monoxide poisoning.

Authors:  Wenping Xiang; Hui Xue; Baojun Wang; Yuechun Li; Jun Zhang; Changchun Jiang; Furu Liang; Jiangxia Pang; Lehua Yu
Journal:  Drug Des Devel Ther       Date:  2017-02-23       Impact factor: 4.162

4.  The Efficacy of N-Butylphthalide and Dexamethasone Combined with Hyperbaric Oxygen on Delayed Encephalopathy After Acute Carbon Monoxide Poisoning.

Authors:  Jiefang Zhang; Yuewen Guo; Wenyao Li; Guangli Li; Yankun Chen
Journal:  Drug Des Devel Ther       Date:  2020-04-02       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.